Pharmaceuticals in North America
Pharmaceuticals in North America
SUMMARY
Pharmaceuticals in North America industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Pharmaceuticals in North America industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The North American pharmaceuticals market had total revenues of $438,442.9m in 2019, representing a compound annual growth rate (CAGR) of 3.4% between 2015 and 2019.
- For the most part, the North American pharmaceuticals market consists of the mixed economies of Canada, Mexico and the US. While the US and Canada are highly developed markets, their healthcare is fundamentally different
- A growing middle class and better access to health care services are greatly increasing consumer demand for pharmaceutical products, including generics, in Mexico.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in North America
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in North America
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the North America pharmaceuticals market with five year forecasts
- What was the size of the North America pharmaceuticals market by value in 2019?
- What will be the size of the North America pharmaceuticals market in 2024?
- What factors are affecting the strength of competition in the North America pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitiors in North America's pharmaceuticals market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What strategies do leading players follow?
7.4. What strategies do leading players follow?
7.5. What has been the rationale behind recent M&A activity?
7.6. How does government regulation impact leading players?
7.7. What impact is COVID-19 having on the market?
8 COMPANY PROFILES
8.1. Johnson & Johnson
8.2. Pfizer Inc.
8.3. AstraZeneca AB
8.4. Apotex Pharmachem Inc
8.5. Bayer AG
8.6. Merck & Co., Inc.
9 APPENDIX
9.1. Methodology
9.2. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What strategies do leading players follow?
7.4. What strategies do leading players follow?
7.5. What has been the rationale behind recent M&A activity?
7.6. How does government regulation impact leading players?
7.7. What impact is COVID-19 having on the market?
8 COMPANY PROFILES
8.1. Johnson & Johnson
8.2. Pfizer Inc.
8.3. AstraZeneca AB
8.4. Apotex Pharmachem Inc
8.5. Bayer AG
8.6. Merck & Co., Inc.
9 APPENDIX
9.1. Methodology
9.2. About MarketLine
LIST OF TABLES
Table 1: North America pharmaceuticals market value: $ billion, 2015-19
Table 2: North America pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: North America pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: North America pharmaceuticals market share: % share, by value, 2019
Table 5: Johnson & Johnson: key facts
Table 6: Johnson & Johnson: Annual Financial Ratios
Table 7: Johnson & Johnson: Key Employees
Table 8: Johnson & Johnson: Key Employees Continued
Table 9: Pfizer Inc.: key facts
Table 10: Pfizer Inc.: Annual Financial Ratios
Table 11: Pfizer Inc.: Key Employees
Table 12: Pfizer Inc.: Key Employees Continued
Table 13: AstraZeneca AB: key facts
Table 14: AstraZeneca AB: Key Employees
Table 15: Apotex Pharmachem Inc: key facts
Table 16: Apotex Pharmachem Inc: Key Employees
Table 17: Bayer AG: key facts
Table 18: Bayer AG: Annual Financial Ratios
Table 19: Bayer AG: Key Employees
Table 20: Merck & Co., Inc.: key facts
Table 21: Merck & Co., Inc.: Annual Financial Ratios
Table 22: Merck & Co., Inc.: Key Employees
Table 23: Merck & Co., Inc.: Key Employees Continued
Table 1: North America pharmaceuticals market value: $ billion, 2015-19
Table 2: North America pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: North America pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: North America pharmaceuticals market share: % share, by value, 2019
Table 5: Johnson & Johnson: key facts
Table 6: Johnson & Johnson: Annual Financial Ratios
Table 7: Johnson & Johnson: Key Employees
Table 8: Johnson & Johnson: Key Employees Continued
Table 9: Pfizer Inc.: key facts
Table 10: Pfizer Inc.: Annual Financial Ratios
Table 11: Pfizer Inc.: Key Employees
Table 12: Pfizer Inc.: Key Employees Continued
Table 13: AstraZeneca AB: key facts
Table 14: AstraZeneca AB: Key Employees
Table 15: Apotex Pharmachem Inc: key facts
Table 16: Apotex Pharmachem Inc: Key Employees
Table 17: Bayer AG: key facts
Table 18: Bayer AG: Annual Financial Ratios
Table 19: Bayer AG: Key Employees
Table 20: Merck & Co., Inc.: key facts
Table 21: Merck & Co., Inc.: Annual Financial Ratios
Table 22: Merck & Co., Inc.: Key Employees
Table 23: Merck & Co., Inc.: Key Employees Continued
LIST OF FIGURES
Figure 1: North America pharmaceuticals market value: $ billion, 2015-19
Figure 2: North America pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: North America pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in North America, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in North America, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in North America, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in North America, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in North America, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in North America, 2019
Figure 10: North America pharmaceuticals market share: % share, by value, 2019
Figure 1: North America pharmaceuticals market value: $ billion, 2015-19
Figure 2: North America pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: North America pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in North America, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in North America, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in North America, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in North America, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in North America, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in North America, 2019
Figure 10: North America pharmaceuticals market share: % share, by value, 2019
